ADMA Biologics (ADMA) Stock Highlights

17.4 | -2.79%

2024-12-21 02:11:36

ADMA Biologics Inc is an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing and developing specialty plasma-derived biologics for the treatment of immunodeficient patients at risk for infection and others at risk for certain infectious diseases. Its targeted patient populations include immune-compromised individuals who suffer from an underlying immune deficiency disorder or who may be immune-suppressed for medical reasons. The company sells plasma-derived intermediate fractions to certain customers, which are generated as part of its FDA-approved manufacturing process for IG and IVIG products. It also provides laboratory contracting services to certain customers and anticipates providing contract filling, labeling and packing services.

Statistics

Range Today

17.08 17.96

Volume Today 6.94M

Range 1 Year

4.06 23.64

Volume 1 Year 884.69M

Range 3 Year

1.17 23.64

Volume 3 Year 2.13B

Range 10 Year

1.01 23.64

Volume 10 Year 4.35B

Highlights

Market Capitalization 5.27B (mid)

Floating Shares 232.04M

Current Price 17.4

Price To Earnings 148.29

Price To Revenue 12.24

Price To Book 23.06

Earnings Per Share 0.14

Payout Ratio 0%

Performance

Latest -2.79%

1 Month -15.66%

3 Months -12.43%

6 Months +60.81%

1 Year +310.38%

3 Years +1292%

5 Years +313.3%

10 Years +59.49%

Benchmarks

Market Capitalization

112 / 368

Gross Profits

70 / 278

Total Revenue

50 / 300

Total Rank

222 / 368

Free Cashflow

126 / 352

Performance 5 years

23 / 368

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.